1	Activation	Activation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	Mycobacterium	Mycobacterium	_	_	_	_	_	_	_
6	tuberculosis-	tuberculosis-	_	_	_	_	_	_	_
7	induced	induce	_	_	_	_	_	_	_
8	interleukin-2	interleukin-2	_	_	_	_	_	_	_
9	receptor	receptor	_	_	_	_	_	_	_
10	expression	expression	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	mononuclear	mononuclear	_	_	_	_	_	_	_
13	phagocytes	phagocyte	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Soluble	soluble	_	_	_	_	_	_	_
2	interleukin-2	interleukin-2	_	_	_	_	_	_	_
3	receptor-alpha	receptor-alpha	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	IL-2Ralpha	IL-2Ralpha	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	has	have	_	_	_	_	_	_	_
8	been	be	_	_	_	_	_	_	_
9	reported	report	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	be	be	_	_	_	_	_	_	_
12	increased	increase	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	sera	serum	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	patients	patient	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	advanced	advance	_	_	_	_	_	_	_
20	tuberculosis	tuberculosis	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	levels	level	_	_	_	_	_	_	_
24	decline	decline	_	_	_	_	_	_	_
25	after	after	_	_	_	_	_	_	_
26	therapy	therapy	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	accordance	accordance	_	_	_	_	_	_	_
29	with	with	_	_	_	_	_	_	_
30	improvement	improvement	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	radiologic	radiologic	_	_	_	_	_	_	_
33	findings	finding	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	investigated	investigate	_	_	_	_	_	_	_
3	expression	expression	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	IL-2Ralpha	IL-2Ralpha	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	bronchoalveolar	bronchoalveolar	_	_	_	_	_	_	_
9	lavage	lavage	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	BAL	BAL	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	active	active	_	_	_	_	_	_	_
16	pulmonary	pulmonary	_	_	_	_	_	_	_
17	tuberculosis	tuberculosis	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	evaluated	evaluate	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	mechanism	mechanism	_	_	_	_	_	_	_
23	Mycobacterium	Mycobacterium	_	_	_	_	_	_	_
24	tuberculosis	tuberculosis	_	_	_	_	_	_	_
25	induces	induce	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	IL-2Ralpha	IL-2Ralpha	_	_	_	_	_	_	_
29	using	use	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	THP-1	thp-1	_	_	_	_	_	_	_
32	mononuclear	mononuclear	_	_	_	_	_	_	_
33	phagocyte	phagocyte	_	_	_	_	_	_	_
34	cell	cell	_	_	_	_	_	_	_
35	line	line	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	found	find	_	_	_	_	_	_	_
3	IL-2Ralpha	IL-2Ralpha	_	_	_	_	_	_	_
4	expression	expression	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	be	be	_	_	_	_	_	_	_
7	increased	increase	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	BAL	bal	_	_	_	_	_	_	_
10	cells	cell	_	_	_	_	_	_	_
11	from	from	_	_	_	_	_	_	_
12	involved	involve	_	_	_	_	_	_	_
13	sites	site	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	active	active	_	_	_	_	_	_	_
16	pulmonary	pulmonary	_	_	_	_	_	_	_
17	tuberculosis	tuberculosis	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	Expression	expression	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	alpha-chain	alpha-chain	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	IL-2Ralpha	IL-2Ralpha	_	_	_	_	_	_	_
7	on	on	_	_	_	_	_	_	_
8	peripheral	peripheral	_	_	_	_	_	_	_
9	blood	blood	_	_	_	_	_	_	_
10	monocytes	monocyte	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	PBM	PBM	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	was	be	_	_	_	_	_	_	_
15	induced	induce	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	M.	M.	_	_	_	_	_	_	_
18	tuberculosis	tuberculosis	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	flow	flow	_	_	_	_	_	_	_
21	cytometry	cytometry	_	_	_	_	_	_	_
22	evaluation	evaluation	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Northern	Northern	_	_	_	_	_	_	_
2	analysis	analysis	_	_	_	_	_	_	_
3	demonstrated	demonstrate	_	_	_	_	_	_	_
4	increased	increase	_	_	_	_	_	_	_
5	IL-2Ralpha	IL-2Ralpha	_	_	_	_	_	_	_
6	gene	gene	_	_	_	_	_	_	_
7	expression	expression	_	_	_	_	_	_	_
8	after	after	_	_	_	_	_	_	_
9	stimulation	stimulation	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	M.	M.	_	_	_	_	_	_	_
12	tuberculosis	tuberculosis	_	_	_	_	_	_	_
13	which	which	_	_	_	_	_	_	_
14	was	be	_	_	_	_	_	_	_
15	further	further	_	_	_	_	_	_	_
16	induced	induce	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	interferon-gamma	interferon-gamma	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	IL-2Ralpha	IL-2Ralpha	_	_	_	_	_	_	_
3	promoter	promoter	_	_	_	_	_	_	_
4	containing	contain	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	nuclear	nuclear	_	_	_	_	_	_	_
7	factor	factor	_	_	_	_	_	_	_
8	kappa	kappa	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	site	site	_	_	_	_	_	_	_
14	was	be	_	_	_	_	_	_	_
15	transcriptionally	transcriptionally	_	_	_	_	_	_	_
16	induced	induce	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	M.	M.	_	_	_	_	_	_	_
19	tuberculosis	tuberculosis	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	this	this	_	_	_	_	_	_	_
22	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
23	site	site	_	_	_	_	_	_	_
24	could	could	_	_	_	_	_	_	_
25	confer	confer	_	_	_	_	_	_	_
26	inducibility	inducibility	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	a	a	_	_	_	_	_	_	_
29	heterologous	heterologous	_	_	_	_	_	_	_
30	herpes	herpes	_	_	_	_	_	_	_
31	thymidine	thymidine	_	_	_	_	_	_	_
32	kinase	kinase	_	_	_	_	_	_	_
33	(	(	_	_	_	_	_	_	_
34	TK	TK	_	_	_	_	_	_	_
35	)	)	_	_	_	_	_	_	_
36	promoter	promoter	_	_	_	_	_	_	_
37	by	by	_	_	_	_	_	_	_
38	M.	M.	_	_	_	_	_	_	_
39	tuberculosis	tuberculosis	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	Electrophoretic	electrophoretic	_	_	_	_	_	_	_
2	mobility	mobility	_	_	_	_	_	_	_
3	shift	shift	_	_	_	_	_	_	_
4	assays	assay	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	EMSAs	EMSA	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	revealed	reveal	_	_	_	_	_	_	_
9	specific	specific	_	_	_	_	_	_	_
10	binding	binding	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	nuclear	nuclear	_	_	_	_	_	_	_
13	protein	protein	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
17	site	site	_	_	_	_	_	_	_
18	upon	upon	_	_	_	_	_	_	_
19	induction	induction	_	_	_	_	_	_	_
20	with	with	_	_	_	_	_	_	_
21	M.	M.	_	_	_	_	_	_	_
22	tuberculosis	tuberculosis	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Using	use	_	_	_	_	_	_	_
2	antibodies	antibody	_	_	_	_	_	_	_
3	against	against	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	p50	p50	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	p65	p65	_	_	_	_	_	_	_
8	subunits	subunit	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	EMSAs	EMSA	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	involvement	involvement	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	both	both	_	_	_	_	_	_	_
18	p50	p50	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	p65	p65	_	_	_	_	_	_	_
21	proteins	protein	_	_	_	_	_	_	_
22	was	be	_	_	_	_	_	_	_
23	further	further	_	_	_	_	_	_	_
24	demonstrated	demonstrate	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Functional	functional	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	IL-2Ralpha	IL-2Ralpha	_	_	_	_	_	_	_
6	on	on	_	_	_	_	_	_	_
7	mononuclear	mononuclear	_	_	_	_	_	_	_
8	phagocytes	phagocyte	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	M.	M.	_	_	_	_	_	_	_
11	tuberculosis	tuberculosis	_	_	_	_	_	_	_
12	infection	infection	_	_	_	_	_	_	_
13	may	may	_	_	_	_	_	_	_
14	play	play	_	_	_	_	_	_	_
15	an	an	_	_	_	_	_	_	_
16	important	important	_	_	_	_	_	_	_
17	immunomodulatory	immunomodulatory	_	_	_	_	_	_	_
18	role	role	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	host	host	_	_	_	_	_	_	_
22	response	response	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

